Nuvalent | Investor Presentation Deck | 42 slides · page 24 of 42
The chart shows pharmacokinetic data across five dose cohorts, demonstrating that the 150mg dose consistently stays above the predicted CNS efficacy thresholds.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
line bullet paragraph source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1